Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NRXN2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |
mRNA | SLC8A2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | DYRK1B | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | UNC79 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | C18orf32 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | KIF1A | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | IRAK1BP1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | DPYSL5 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | ACVR2B | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |